UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Risk factors for venous thromboembolism in metastatic colorectal cancer with contemporary treatment: A SEER‐Medicare analysis

Cancer medicine (Malden, MA), 2022-04, Vol.11 (8), p.1817-1826

2022

Volltextzugriff (PDF)

Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study

International journal of clinical oncology, 2017-04, Vol.22 (2), p.397-404

2017

Volltextzugriff (PDF)

Survival and Recurrence Patterns after Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) for Locally Advanced Esophagogastric Adenocarcinoma

Annals of surgical oncology, 2015-01, Vol.22 (1), p.324-330

2015

Volltextzugriff (PDF)

In-advance end-of-life discussions and the quality of inpatient end-of-life care: a pilot study in bereaved primary caregivers of advanced cancer patients

Supportive care in cancer, 2013-02, Vol.21 (2), p.629-636

2013

Volltextzugriff (PDF)

A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma

Cancer medicine (Malden, MA), 2023-06, Vol.12 (12), p.13100-13110

2023

Volltextzugriff (PDF)

Adjuvant chemotherapy for colon cancer in the elderly: moving from evidence to practice

Oncology (Williston Park, N.Y.), 2009-02, Vol.23 (2), p.162

Ades, Steven

2009

Volltextzugriff (PDF)

NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors

Biomarker research, 2018-04, Vol.6 (1), p.15-15, Article 15

2018

Volltextzugriff (PDF)

Tu1422 VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH PANCREATIC ADENOCARCINOMA (PAC): PREVALALENCE, RISK-ASSESSMENT, AND INITIATION OF AMBULATORY THROMBOPROPHYLAXIS (AT)

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1334-S-1334

2024

Volltextzugriff (PDF)

Selected class I and class II HLA alleles and haplotypes and risk of high‐grade cervical intraepithelial neoplasia

International journal of cancer, 2008-06, Vol.122 (12), p.2820-2826

2008

Volltextzugriff (PDF)

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

The lancet oncology, 2021-07, Vol.22 (7), p.931-945

2021

Volltextzugriff (PDF)

Cost-effectiveness of abiraterone acetate for high-risk nnon-metastatic prostate cancer

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.358-358

2023

Volltextzugriff (PDF)

Crizotinib in Patients With MET-Amplified NSCLC

Journal of thoracic oncology, 2021-06, Vol.16 (6), p.1017-1029

2021

Volltextzugriff (PDF)

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

The lancet oncology, 2017-09, Vol.18 (9), p.1159-1171

2017

Volltextzugriff (PDF)

Implementing guidelines to prevent cancer associated thrombosis: how can we do better?

Research and practice in thrombosis and haemostasis, 2023-01, Vol.7 (1), p.100038-100038, Article 100038

2023

Volltextzugriff (PDF)

Bleeding Risk in a Cohort of Ambulatory Cancer Patients Receiving Outpatient Prophylactic Anticoagulation for Venous Thrombosis Prevention

Blood, 2019-11, Vol.134 (Supplement_1), p.709-709

2019

Volltextzugriff (PDF)

Nivolumab‐Induced Thrombotic Thrombocytopenic Purpura in a Patient with Anal Squamous Cell Carcinoma: A Lesson on Hematologic Toxicity from Immunotherapy

The oncologist (Dayton, Ohio), 2020-12, Vol.25 (12), p.1009-1012

2020

Volltextzugriff (PDF)

Risk factors for cancer‐associated venous thromboembolism: The venous thromboembolism prevention in the ambulatory cancer clinic (VTE‐PACC) study

Journal of thrombosis and haemostasis, 2019-12, Vol.17 (12), p.2152-2159

2019

Volltextzugriff (PDF)

Venous thromboembolism prevention program implementation in a community oncology practice: a cohort study

Lancet Regional Health - Americas (Online), 2024-10, Vol.38, p.100866, Article 100866

2024

Volltextzugriff (PDF)

Enhancing the Khorana Score: Traditional VTE Risk Factors Are Important in Predicting Long Term VTE Risk in Cancer Patients Initiating Chemotherapy

Blood, 2017-12, Vol.130 (Suppl_1), p.753-753

2017

Volltextzugriff (PDF)

Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic (VTE-PACC): a Systems-Based, Personalized, Multidisciplinary Program to Increase Venous Thromboembolism (VTE) Risk Assessment, Education and Anticoagulant Prophylaxis in Cancer Outpatients Initiating Therapy

Blood, 2017-12, Vol.130, p.217-217

2017

Volltextzugriff (PDF)

Improving Rural Clinical Trial Enrollment: Recommendations From the Rural Health Working Group of the Alliance Clinical Trials Network

Journal of clinical oncology, 2024-05, Vol.42 (14), p.1722-1725

2024

Volltextzugriff (PDF)

Statin therapy and levels of hemostatic factors in a healthy population: the Multi‐Ethnic Study of Atherosclerosis

Journal of thrombosis and haemostasis, 2013-06, Vol.11 (6), p.1078-1084

2013

Volltextzugriff (PDF)

Risk Factors for Venous Thromboembolism in Metastatic Colon Cancer Patients in the Contemporary Treatment Era: A SEER-Medicare Data Analysis

Blood, 2016-12, Vol.128 (22), p.2598-2598

2016

Volltextzugriff (PDF)

The Potential for Overtreatment With Total Neoadjuvant Therapy (TNT): Consider One Local Therapy Instead

Clinical colorectal cancer, 2022-03, Vol.21 (1), p.19-35

2022

Volltextzugriff (PDF)

Implementation of a cancer-associated thrombosis prevention program at a rural cancer center

Research and practice in thrombosis and haemostasis, 2024-01, Vol.8 (1), p.102286-102286, Article 102286

2024

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Englisch
(111)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Risk factors for venous thromboembolism in metastatic colorectal cancer with contemporary treatment: A SEER‐Medicare analysis

Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study

Survival and Recurrence Patterns after Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) for Locally Advanced Esophagogastric Adenocarcinoma

In-advance end-of-life discussions and the quality of inpatient end-of-life care: a pilot study in bereaved primary caregivers of advanced cancer patients

A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma

Adjuvant chemotherapy for colon cancer in the elderly: moving from evidence to practice

NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors

Tu1422 VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH PANCREATIC ADENOCARCINOMA (PAC): PREVALALENCE, RISK-ASSESSMENT, AND INITIATION OF AMBULATORY THROMBOPROPHYLAXIS (AT)

Selected class I and class II HLA alleles and haplotypes and risk of high‐grade cervical intraepithelial neoplasia

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Cost-effectiveness of abiraterone acetate for high-risk nnon-metastatic prostate cancer

Crizotinib in Patients With MET-Amplified NSCLC

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Implementing guidelines to prevent cancer associated thrombosis: how can we do better?

Bleeding Risk in a Cohort of Ambulatory Cancer Patients Receiving Outpatient Prophylactic Anticoagulation for Venous Thrombosis Prevention

Nivolumab‐Induced Thrombotic Thrombocytopenic Purpura in a Patient with Anal Squamous Cell Carcinoma: A Lesson on Hematologic Toxicity from Immunotherapy

Risk factors for cancer‐associated venous thromboembolism: The venous thromboembolism prevention in the ambulatory cancer clinic (VTE‐PACC) study

Venous thromboembolism prevention program implementation in a community oncology practice: a cohort study

Enhancing the Khorana Score: Traditional VTE Risk Factors Are Important in Predicting Long Term VTE Risk in Cancer Patients Initiating Chemotherapy

Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic (VTE-PACC): a Systems-Based, Personalized, Multidisciplinary Program to Increase Venous Thromboembolism (VTE) Risk Assessment, Education and Anticoagulant Prophylaxis in Cancer Outpatients Initiating Therapy

Improving Rural Clinical Trial Enrollment: Recommendations From the Rural Health Working Group of the Alliance Clinical Trials Network

Statin therapy and levels of hemostatic factors in a healthy population: the Multi‐Ethnic Study of Atherosclerosis

Risk Factors for Venous Thromboembolism in Metastatic Colon Cancer Patients in the Contemporary Treatment Era: A SEER-Medicare Data Analysis

The Potential for Overtreatment With Total Neoadjuvant Therapy (TNT): Consider One Local Therapy Instead

Implementation of a cancer-associated thrombosis prevention program at a rural cancer center

Suchergebnisse filtern